This report contains market size and forecasts of Microscopic Polyangiitis (MPA) Treatment in Global, including the following market information:
Global Microscopic Polyangiitis (MPA) Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Microscopic Polyangiitis (MPA) Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Microscopic Polyangiitis (MPA) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Microscopic Polyangiitis (MPA) Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Microscopic Polyangiitis (MPA) Treatment Market Segment Percentages, By Type, 2020 (%)
Avacopan
Immune Globulin
Rituximab Biosimilar
Others
China Microscopic Polyangiitis (MPA) Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Microscopic Polyangiitis (MPA) Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Others
Global Microscopic Polyangiitis (MPA) Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Microscopic Polyangiitis (MPA) Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Microscopic Polyangiitis (MPA) Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Microscopic Polyangiitis (MPA) Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Celltrion Inc
ChemoCentryx Inc
Sandoz International GmbH
Teijin Pharma Ltd
TTY Biopharm Company Ltd
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Microscopic Polyangiitis (MPA) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Microscopic Polyangiitis (MPA) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Microscopic Polyangiitis (MPA) Treatment Overall Market Size
2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size: 2021 VS 2027
2.2 Global Microscopic Polyangiitis (MPA) Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Microscopic Polyangiitis (MPA) Treatment Players in Global Market
3.2 Top Global Microscopic Polyangiitis (MPA) Treatment Companies Ranked by Revenue
3.3 Global Microscopic Polyangiitis (MPA) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Microscopic Polyangiitis (MPA) Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Microscopic Polyangiitis (MPA) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Microscopic Polyangiitis (MPA) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Microscopic Polyangiitis (MPA) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Microscopic Polyangiitis (MPA) Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Microscopic Polyangiitis (MPA) Treatment Market Size Markets, 2021 & 2027
4.1.2 Avacopan
4.1.3 Immune Globulin
4.1.4 Rituximab Biosimilar
4.1.5 Others
4.2 By Type - Global Microscopic Polyangiitis (MPA) Treatment Revenue & Forecasts
4.2.1 By Type - Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2016-2021
4.2.2 By Type - Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2022-2027
4.2.3 By Type - Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Microscopic Polyangiitis (MPA) Treatment Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Microscopic Polyangiitis (MPA) Treatment Revenue & Forecasts
5.2.1 By Application - Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2016-2021
5.2.2 By Application - Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2022-2027
5.2.3 By Application - Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Microscopic Polyangiitis (MPA) Treatment Market Size, 2021 & 2027
6.2 By Region - Global Microscopic Polyangiitis (MPA) Treatment Revenue & Forecasts
6.2.1 By Region - Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2016-2021
6.2.2 By Region - Global Microscopic Polyangiitis (MPA) Treatment Revenue, 2022-2027
6.2.3 By Region - Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Microscopic Polyangiitis (MPA) Treatment Revenue, 2016-2027
6.3.2 US Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.3.3 Canada Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.3.4 Mexico Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Microscopic Polyangiitis (MPA) Treatment Revenue, 2016-2027
6.4.2 Germany Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.4.3 France Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.4.4 U.K. Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.4.5 Italy Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.4.6 Russia Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.4.8 Benelux Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Microscopic Polyangiitis (MPA) Treatment Revenue, 2016-2027
6.5.2 China Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.5.3 Japan Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.5.4 South Korea Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.5.6 India Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Microscopic Polyangiitis (MPA) Treatment Revenue, 2016-2027
6.6.2 Brazil Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.6.3 Argentina Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Microscopic Polyangiitis (MPA) Treatment Revenue, 2016-2027
6.7.2 Turkey Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.7.3 Israel Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
6.7.5 UAE Microscopic Polyangiitis (MPA) Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Celltrion Inc
7.1.1 Celltrion Inc Corporate Summary
7.1.2 Celltrion Inc Business Overview
7.1.3 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Major Product Offerings
7.1.4 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Revenue in Global (2016-2021)
7.1.5 Celltrion Inc Key News
7.2 ChemoCentryx Inc
7.2.1 ChemoCentryx Inc Corporate Summary
7.2.2 ChemoCentryx Inc Business Overview
7.2.3 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Major Product Offerings
7.2.4 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Revenue in Global (2016-2021)
7.2.5 ChemoCentryx Inc Key News
7.3 Sandoz International GmbH
7.3.1 Sandoz International GmbH Corporate Summary
7.3.2 Sandoz International GmbH Business Overview
7.3.3 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Major Product Offerings
7.3.4 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Revenue in Global (2016-2021)
7.3.5 Sandoz International GmbH Key News
7.4 Teijin Pharma Ltd
7.4.1 Teijin Pharma Ltd Corporate Summary
7.4.2 Teijin Pharma Ltd Business Overview
7.4.3 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Major Product Offerings
7.4.4 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Revenue in Global (2016-2021)
7.4.5 Teijin Pharma Ltd Key News
7.5 TTY Biopharm Company Ltd
7.5.1 TTY Biopharm Company Ltd Corporate Summary
7.5.2 TTY Biopharm Company Ltd Business Overview
7.5.3 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Major Product Offerings
7.5.4 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Revenue in Global (2016-2021)
7.5.5 TTY Biopharm Company Ltd Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Microscopic Polyangiitis (MPA) Treatment Market Opportunities & Trends in Global Market
Table 2. Microscopic Polyangiitis (MPA) Treatment Market Drivers in Global Market
Table 3. Microscopic Polyangiitis (MPA) Treatment Market Restraints in Global Market
Table 4. Key Players of Microscopic Polyangiitis (MPA) Treatment in Global Market
Table 5. Top Microscopic Polyangiitis (MPA) Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Microscopic Polyangiitis (MPA) Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Microscopic Polyangiitis (MPA) Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Microscopic Polyangiitis (MPA) Treatment Product Type
Table 9. List of Global Tier 1 Microscopic Polyangiitis (MPA) Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Microscopic Polyangiitis (MPA) Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Celltrion Inc
ChemoCentryx Inc
Sandoz International GmbH
Teijin Pharma Ltd
TTY Biopharm Company Ltd